Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program, Human Molecular Genetics, vol.15, issue.5, pp.691-703, 2006. ,
DOI : 10.1093/hmg/ddi483
URL : https://hal.archives-ouvertes.fr/hal-00187833
Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons, J Neurosci, vol.27, pp.7318-7328, 2007. ,
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death, Nature, vol.19, issue.7010, pp.805-810, 2004. ,
DOI : 10.1016/j.nbd.2004.04.001
Safety and Tolerability Assessment of Intrastriatal Neural Allografts in Five Patients with Huntington's Disease, Experimental Neurology, vol.161, issue.1, pp.194-202, 2000. ,
DOI : 10.1006/exnr.1999.7239
Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study, The Lancet Neurology, vol.5, issue.4, pp.303-309, 2006. ,
DOI : 10.1016/S1474-4422(06)70381-7
Motor and cognitive improvements in patients with Huntington's disease after neural transplantation, The Lancet, vol.356, issue.9246, pp.1975-1979, 2000. ,
DOI : 10.1016/S0140-6736(00)03310-9
Mouse Models of Triplet Repeat Diseases, Molecular Biotechnology, vol.32, issue.2, pp.147-158, 2006. ,
DOI : 10.1385/MB:32:2:147
Experimental therapeutics in transgenic mouse models of Huntington's disease, Nature Reviews Neuroscience, vol.40, issue.5, pp.373-384, 2004. ,
DOI : 10.1038/ng864
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation, Science, vol.292, issue.5521, pp.1552-1555, 2001. ,
DOI : 10.1126/science.292.5521.1552
Global changes to the ubiquitin system in Huntington's disease, Nature, vol.353, issue.7154, pp.704-708, 2007. ,
DOI : 10.1038/nature06022
Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases, Proceedings of the National Academy of Sciences, vol.103, issue.11, pp.4246-4251, 2006. ,
DOI : 10.1073/pnas.0511256103
Chaperoning brain degeneration, Proceedings of the National Academy of Sciences, vol.99, issue.Supplement 4, pp.16407-16411, 2002. ,
DOI : 10.1073/pnas.152330499
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC139901
Silencing Polyglutamine Degeneration with RNAi, Neuron, vol.48, issue.5, pp.715-718, 2005. ,
DOI : 10.1016/j.neuron.2005.11.008
Huntington???s disease: from huntingtin function and dysfunction to therapeutic strategies, Cellular and Molecular Life Sciences, vol.63, issue.22, pp.2642-2660, 2006. ,
DOI : 10.1007/s00018-006-6242-0
Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes ,
Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation, Human Molecular Genetics, vol.14, issue.5, pp.679-691, 2005. ,
DOI : 10.1093/hmg/ddi064
Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington???s disease patients, Biochemical and Biophysical Research Communications, vol.359, issue.2, pp.335-340, 2007. ,
DOI : 10.1016/j.bbrc.2007.05.093
Interaction of Akt-Phosphorylated Ataxin-1 with 14-3-3 Mediates Neurodegeneration in Spinocerebellar Ataxia Type 1, Cell, vol.113, issue.4, pp.457-468, 2003. ,
DOI : 10.1016/S0092-8674(03)00349-0
A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse, Proceedings of the National Academy of Sciences, vol.104, issue.42, pp.16685-16689, 2007. ,
DOI : 10.1073/pnas.0707842104
Akt is altered in an animal model of Huntington's disease and in patients, European Journal of Neuroscience, vol.293, issue.6, pp.1478-1488, 2005. ,
DOI : 10.1111/j.1460-9568.2005.03985.x
Transcriptional Repression of PGC-1?? by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration, Cell, vol.127, issue.1, pp.59-69, 2006. ,
DOI : 10.1016/j.cell.2006.09.015
Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1, Nature Genetics, vol.19, issue.2, pp.148-154, 1998. ,
DOI : 10.1038/502
Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 Mice, Neuron, vol.24, issue.4, pp.879-892, 1999. ,
DOI : 10.1016/S0896-6273(00)81035-1
Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation, Cell, vol.90, issue.3, pp.537-548, 1997. ,
DOI : 10.1016/S0092-8674(00)80513-9
Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers, Journal of Biological Chemistry, vol.280, issue.17, pp.17294-17300, 2005. ,
DOI : 10.1074/jbc.M500997200
Biologically active molecules that reduce polyglutamine aggregation and toxicity, Human Molecular Genetics, vol.15, issue.13, pp.2114-2124, 2006. ,
DOI : 10.1093/hmg/ddl135
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain, Science, vol.277, issue.5334, pp.1990-1993, 1997. ,
DOI : 10.1126/science.277.5334.1990
Weight loss in early stage of Huntington's disease, Neurology, vol.59, issue.9, pp.1325-1330, 2002. ,
DOI : 10.1212/01.WNL.0000031791.10922.CF
Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice, Nat Genet, vol.26, pp.300-306, 2000. ,
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers, Nature structural & molecular biology, vol.266, issue.6, pp.558-566, 2008. ,
DOI : 10.1006/jmbi.2001.4538
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models, Human Molecular Genetics, vol.15, issue.18, pp.2743-2751, 2006. ,
DOI : 10.1093/hmg/ddl210
Serine 776 of Ataxin-1 Is Critical for Polyglutamine-Induced Disease in SCA1 Transgenic Mice, Neuron, vol.38, issue.3, pp.375-387, 2003. ,
DOI : 10.1016/S0896-6273(03)00258-7
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice, J Neurosci, vol.23, pp.9418-9427, 2003. ,
Heat Shock Transcription Factor 1-activating Compounds Suppress Polyglutamine-induced Neurodegeneration through Induction of Multiple Molecular Chaperones, Journal of Biological Chemistry, vol.283, issue.38, pp.26188-26197, 2008. ,
DOI : 10.1074/jbc.M710521200
Calpain activation in Huntington's disease, J Neurosci, vol.22, pp.4842-4849, 2002. ,
Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease, Journal of Biological Chemistry, vol.280, issue.1, pp.556-563, 2005. ,
DOI : 10.1074/jbc.M410210200
Diseases of Unstable Repeat Expansion: Mechanisms and Common Principles, Nature Reviews Genetics, vol.101, issue.10, pp.743-755, 2005. ,
DOI : 10.1038/nrg1691
Concepts in sumoylation: a decade on, Nature Reviews Molecular Cell Biology, vol.1773, issue.12, pp.947-956, 2007. ,
DOI : 10.1038/nrm2293
Mechanisms of neurodegeneration in Huntington???s disease, European Journal of Neuroscience, vol.35, issue.1, pp.2803-2820, 2008. ,
DOI : 10.1111/j.1460-9568.2008.06310.x
A Protein Interaction Network Links GIT1, an Enhancer of Huntingtin Aggregation, to Huntington's Disease, Molecular Cell, vol.15, issue.6, pp.853-865, 2004. ,
DOI : 10.1016/j.molcel.2004.09.016
Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract, Nature Genetics, vol.53, issue.4, pp.442-449, 1996. ,
DOI : 10.1038/377248a0
Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin, Cell, vol.125, issue.6, pp.1179-1191, 2006. ,
DOI : 10.1016/j.cell.2006.04.026
Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology, J Neurosci, vol.19, pp.2522-2534, 1999. ,
The hunt for huntingtin function: interaction partners tell many different stories, Trends in Biochemical Sciences, vol.28, issue.8, pp.425-433, 2003. ,
DOI : 10.1016/S0968-0004(03)00168-3
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model, Proceedings of the National Academy of Sciences, vol.102, issue.16, pp.5820-5825, 2005. ,
DOI : 10.1073/pnas.0501507102
Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach, Human Molecular Genetics, vol.13, issue.13, pp.1389-1405, 2004. ,
DOI : 10.1093/hmg/ddh144
Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay, Proceedings of the National Academy of Sciences, vol.99, issue.Supplement 4, pp.16400-16406, 2002. ,
DOI : 10.1073/pnas.182426599
Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy, Proceedings of the National Academy of Sciences, vol.97, issue.12, pp.6739-6744, 2000. ,
DOI : 10.1073/pnas.110138997
Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice, Human Molecular Genetics, vol.11, issue.26, pp.3351-3359, 2002. ,
DOI : 10.1093/hmg/11.26.3351
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease, Proc Natl Acad Sci U S A, vol.100, pp.2041-2046, 2003. ,
Regional and cellular gene expression changes in human Huntington's disease brain, Human Molecular Genetics, vol.15, issue.6, pp.965-977, 2006. ,
DOI : 10.1093/hmg/ddl013
The IGF-1/Akt Pathway Is Neuroprotective in Huntington's Disease and Involves Huntingtin Phosphorylation by Akt, Developmental Cell, vol.2, issue.6, pp.831-837, 2002. ,
DOI : 10.1016/S1534-5807(02)00188-0
Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release, Human Molecular Genetics, vol.10, issue.10, pp.1049-1059, 2001. ,
DOI : 10.1093/hmg/10.10.1049
Evidence for irnnairment of energy metabofism in vivo in Huntington's disease using localized 1H NMR spectroscopy, Neurology, vol.43, issue.12, pp.2689-2695, 1993. ,
DOI : 10.1212/WNL.43.12.2689
Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation, Cell, vol.137, issue.1, pp.60-72, 2009. ,
DOI : 10.1016/j.cell.2009.03.018
Hsp70/Hsc70 regulates the effect phosphorylation has on stabilizing ataxin-1, Journal of Neurochemistry, vol.24, issue.6, pp.2040-2048, 2007. ,
DOI : 10.1111/j.1471-4159.2007.04678.x
Huntingtin Is Ubiquitinated and Interacts with a Specific Ubiquitin-conjugating Enzyme, Journal of Biological Chemistry, vol.271, issue.32, pp.19385-19394, 1996. ,
DOI : 10.1074/jbc.271.32.19385
Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration, PLoS Genetics, vol.13, issue.5, p.82, 2007. ,
DOI : 10.1371/journal.pgen.0030082.st005
Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy, Nature Medicine, vol.9, issue.6, pp.768-773, 2003. ,
DOI : 10.1038/nm878
Testosterone Reduction Prevents Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy, Neuron, vol.35, issue.5, pp.843-854, 2002. ,
DOI : 10.1016/S0896-6273(02)00834-6
Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives, Journal of Molecular Medicine, vol.82, issue.5, pp.298-307, 2004. ,
DOI : 10.1007/s00109-004-0530-7
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis, Science, vol.300, issue.5618, pp.486-489, 2003. ,
DOI : 10.1126/science.1079469
Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases, Journal of Biological Chemistry, vol.279, issue.45, pp.46363-46366, 2004. ,
DOI : 10.1074/jbc.C400260200
Ataxin-1 Nuclear Localization and Aggregation, Cell, vol.95, issue.1, pp.41-53, 1998. ,
DOI : 10.1016/S0092-8674(00)81781-X
ATAXIN-1 Interacts with the Repressor Capicua in Its Native Complex to Cause SCA1 Neuropathology, Cell, vol.127, issue.7, pp.1335-1347, 2006. ,
DOI : 10.1016/j.cell.2006.11.038
Wild-Type Huntingtin Reduces the Cellular Toxicity of Mutant Huntingtin In Vivo, The American Journal of Human Genetics, vol.68, issue.2, pp.313-324, 2001. ,
DOI : 10.1086/318207
RNA toxicity is a component of ataxin-3 degeneration in Drosophila, Nature, vol.315, issue.7198, pp.1107-1111, 2008. ,
DOI : 10.1038/nature06909
Huntingtin???protein interactions and the pathogenesis of Huntington's disease, Trends in Genetics, vol.20, issue.3, pp.146-154, 2004. ,
DOI : 10.1016/j.tig.2004.01.008
Multiple pathways contribute to the pathogenesis of Huntington disease, Molecular Neurodegeneration, vol.1, issue.1, p.19, 2006. ,
DOI : 10.1186/1750-1326-1-19
Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1, Nature, vol.437, issue.7188, pp.713-718, 2008. ,
DOI : 10.1038/nature06731
A Protein???Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration, Cell, vol.125, issue.4, pp.801-814, 2006. ,
DOI : 10.1016/j.cell.2006.03.032
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases, Nature, vol.175, issue.7113, pp.787-795, 2006. ,
DOI : 10.1038/nature05292
Linking SNPs to CAG repeat length in Huntington's disease patients, Nature Methods, vol.120, issue.11, pp.951-953, 2008. ,
DOI : 10.1089/hum.2007.116
Proteases Acting on Mutant Huntingtin Generate Cleaved Products that Differentially Build Up Cytoplasmic and Nuclear Inclusions, Molecular Cell, vol.10, issue.2, pp.259-269, 2002. ,
DOI : 10.1016/S1097-2765(02)00602-0
A cellular model that recapitulates major pathogenic steps of Huntington's disease, Human Molecular Genetics, vol.7, issue.9, pp.1355-1361, 1998. ,
DOI : 10.1093/hmg/7.9.1355
Pathological mechanisms in Huntington's disease and other polyglutamine expansion diseases, Essays In Biochemistry, vol.33, pp.149-163, 1998. ,
DOI : 10.1042/bse0330149
Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases, The Journal of Cell Biology, vol.22, issue.4, pp.647-656, 2005. ,
DOI : 10.1038/ng1095-155
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain, Human Molecular Genetics, vol.11, issue.17, pp.1911-1926, 2002. ,
DOI : 10.1093/hmg/11.17.1911
Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects, Human Molecular Genetics, vol.11, issue.17, pp.1927-1937, 2002. ,
DOI : 10.1093/hmg/11.17.1927
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease, Human Molecular Genetics, vol.9, issue.9, pp.1259-1271, 2000. ,
DOI : 10.1093/hmg/9.9.1259
RNA Polymerase II Transcription in Murine Cells Lacking the TATA Binding Protein, Science, vol.298, issue.5595, pp.1036-1039, 2002. ,
DOI : 10.1126/science.1076327
CREB-binding protein sequestration by expanded polyglutamine, Human Molecular Genetics, vol.9, issue.14, pp.2197-2202, 2000. ,
DOI : 10.1093/hmg/9.14.2197
Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils, Proceedings of the National Academy of Sciences, vol.97, issue.14, pp.7841-7846, 2000. ,
DOI : 10.1073/pnas.140202897
Modulation of neurodegeneration by molecular chaperones, Nature Reviews Neuroscience, vol.19, issue.1, pp.11-22, 2005. ,
DOI : 10.1038/nrn1587
Huntington???s disease genetics, NeuroRX, vol.22, issue.2, pp.255-262, 2004. ,
DOI : 10.1602/neurorx.1.2.255
Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila, Human Molecular Genetics, vol.12, issue.11, pp.1253-1259, 2003. ,
DOI : 10.1093/hmg/ddg144
A toxic monomeric conformer of the polyglutamine protein, Nature Structural & Molecular Biology, vol.13, issue.4, pp.332-340, 2007. ,
DOI : 10.1073/pnas.182426599
Conformational Abs recognizing a generic amyloid fibril epitope, Proceedings of the National Academy of Sciences, vol.99, issue.3, pp.1485-1490, 2002. ,
DOI : 10.1073/pnas.022662599
Ectopically Expressed CAG Repeats Cause Intranuclear Inclusions and a Progressive Late Onset Neurological Phenotype in the Mouse, Cell, vol.91, issue.6, pp.753-763, 1997. ,
DOI : 10.1016/S0092-8674(00)80464-X
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines, Nature Neuroscience, vol.5, pp.731-736, 2002. ,
DOI : 10.1038/nn884
Inhibition of Calcineurin by FK506 Protects against Polyglutamine-Huntingtin Toxicity through an Increase of Huntingtin Phosphorylation at S421, Journal of Neuroscience, vol.26, issue.5, pp.1635-1645, 2006. ,
DOI : 10.1523/JNEUROSCI.3706-05.2006
Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases., Proceedings of the National Academy of Sciences, vol.91, issue.12, pp.5355-5358, 1994. ,
DOI : 10.1073/pnas.91.12.5355
Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease Patients, Current Biology, vol.19, issue.9, pp.774-778, 2009. ,
DOI : 10.1016/j.cub.2009.03.030
The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine???421 of huntingtin, European Journal of Neuroscience, vol.276, issue.2, pp.273-279, 2004. ,
DOI : 10.1111/j.0953-816X.2003.03131.x
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease, Nature Genetics, vol.22, issue.6, pp.585-595, 2004. ,
DOI : 10.1073/pnas.0437870100
Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle, Genes & Development, vol.20, issue.16, pp.2183-2192, 2006. ,
DOI : 10.1101/gad.1436506
Protein aggregation and neurodegenerative disease, Nature Medicine, vol.99, issue.7, pp.10-17, 2004. ,
DOI : 10.1038/nm1066
Opinion: What is the role of protein aggregation in neurodegeneration?, Nature Reviews Molecular Cell Biology, vol.62, issue.11, pp.891-898, 2005. ,
DOI : 10.1016/S0733-8619(01)00020-2
Spinocerebellar Ataxia Type 3 (SCA3): Thalamic Neurodegeneration Occurs Independently from Thalamic Ataxin-3 Immunopositive Neuronal Intranuclear Inclusions, Brain Pathology, vol.101, issue.3, pp.218-227, 2006. ,
DOI : 10.1146/annurev.neuro.23.1.217
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders, Nature, vol.19, issue.6921, pp.373-379, 2003. ,
DOI : 10.1038/nature01301
Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions, Cell, vol.95, issue.1, pp.55-66, 1998. ,
DOI : 10.1016/S0092-8674(00)81782-1
Huntingtin Phosphorylation Sites Mapped by Mass Spectrometry: MODULATION OF CLEAVAGE AND TOXICITY, Journal of Biological Chemistry, vol.281, issue.33, pp.23686-23697, 2006. ,
DOI : 10.1074/jbc.M513507200
Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination, Biochemical and Biophysical Research Communications, vol.362, issue.3, pp.734-739, 2007. ,
DOI : 10.1016/j.bbrc.2007.08.062
Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice, Human Molecular Genetics, vol.13, issue.20, pp.2535-2543, 2004. ,
DOI : 10.1093/hmg/ddh268
Amyloid-?? protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory, Nature Medicine, vol.28, issue.8, pp.837-842, 2008. ,
DOI : 10.1038/nm1782
Polyglutamine diseases: emerging concepts in pathogenesis and therapy, Human Molecular Genetics, vol.16, issue.R2, pp.115-123, 2007. ,
DOI : 10.1093/hmg/ddm213
Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease, Human Molecular Genetics, vol.10, issue.12, pp.1307-1315, 2001. ,
DOI : 10.1093/hmg/10.12.1307
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators, Cell, vol.127, issue.2, pp.397-408, 2006. ,
DOI : 10.1016/j.cell.2006.09.024
SUMO Modification of Huntingtin and Huntington's Disease Pathology, Science, vol.304, issue.5667, pp.100-104, 2004. ,
DOI : 10.1126/science.1092194
Transcriptional abnormalities in Huntington disease, Trends in Genetics, vol.19, issue.5, pp.233-238, 2003. ,
DOI : 10.1016/S0168-9525(03)00074-X
High-dose creatine therapy for Huntington disease: A 2-year clinical and MRS study, Neurology, vol.64, issue.9, pp.1655-1656, 2005. ,
DOI : 10.1212/01.WNL.0000160388.96242.77
Androgen-Dependent Neurodegeneration by Polyglutamine-Expanded Human Androgen Receptor in Drosophila, Neuron, vol.35, issue.5, pp.855-864, 2002. ,
DOI : 10.1016/S0896-6273(02)00875-9
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease, Nature Medicine, vol.10, issue.2, pp.148-154, 2004. ,
DOI : 10.1038/nm985
Role of proteolysis in polyglutamine disorders, Journal of Neuroscience Research, vol.293, issue.3, pp.406-416, 2003. ,
DOI : 10.1002/jnr.10746
Identification and Allele-Specific Silencing of the Mutant Huntingtin Allele in Huntington's Disease Patient-Derived Fibroblasts, Human Gene Therapy, vol.19, issue.7, pp.710-719, 2008. ,
DOI : 10.1089/hum.2007.116
Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease, Human Molecular Genetics, vol.14, issue.10, pp.1379-1392, 2005. ,
DOI : 10.1093/hmg/ddi147
Creatine supplementation in Huntington's disease: A placebo-controlled pilot trial, Neurology, vol.61, issue.7, pp.925-930, 2003. ,
DOI : 10.1212/01.WNL.0000090629.40891.4B
Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer, Nature Structural & Molecular Biology, vol.91, issue.12, pp.1215-1222, 2004. ,
DOI : 10.1371/journal.pbio.0020321
A? Oligomers ? a decade of discovery, Journal of Neurochemistry, vol.279, issue.5, pp.1172-1184, 2007. ,
DOI : 10.1038/nn1630
Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation, BMC Neuroscience, vol.6, issue.1, p.1, 2005. ,
DOI : 10.1186/1471-2202-6-1
Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo, Human Molecular Genetics, vol.14, issue.11, pp.1569-1577, 2005. ,
DOI : 10.1093/hmg/ddi165
Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus, Human Molecular Genetics, vol.17, issue.15, pp.2390-2404, 2008. ,
DOI : 10.1093/hmg/ddn139
A Long CAG Repeat in the Mouse Sca1 Locus Replicates SCA1 Features and Reveals the Impact of Protein Solubility on Selective Neurodegeneration, Neuron, vol.34, issue.6, pp.905-919, 2002. ,
DOI : 10.1016/S0896-6273(02)00733-X
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration, Nature Medicine, vol.23, issue.10, pp.1088-1095, 2005. ,
DOI : 10.1046/j.1471-4159.2002.00998.x
Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract, Journal of Biological Chemistry, vol.273, issue.15, pp.9158-9167, 1998. ,
DOI : 10.1074/jbc.273.15.9158
Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion, Nature Genetics, vol.90, issue.4, pp.404-410, 1997. ,
DOI : 10.1016/0006-8993(88)90055-8
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway, Nature Chemical Biology, vol.4, issue.5, pp.295-305, 2008. ,
DOI : 10.1038/nchembio.79
Amelioration of protein misfolding disease by rapamycin: Translation or autophagy?, Autophagy, vol.4, issue.4, pp.542-545, 2008. ,
DOI : 10.4161/auto.6059
RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia, Nature Medicine, vol.278, issue.8, pp.816-820, 2004. ,
DOI : 10.1038/nbt0502-497
Palmitoylation of huntingtin by HIP14is essential for its trafficking and function, Nature Neuroscience, vol.406, issue.6, pp.824-831, 2006. ,
DOI : 10.1038/nn1702
SCA7 Knockin Mice Model Human SCA7 and Reveal Gradual Accumulation of Mutant Ataxin-7 in Neurons and Abnormalities in Short-Term Plasticity, Neuron, vol.37, issue.3, pp.383-401, 2003. ,
DOI : 10.1016/S0896-6273(02)01190-X
Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice, Human Molecular Genetics, vol.9, issue.17, pp.2491-2506, 2000. ,
DOI : 10.1093/hmg/9.17.2491
Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons, Human Molecular Genetics, vol.17, issue.24, 2008. ,
DOI : 10.1093/hmg/ddn281
A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo, Proceedings of the National Academy of Sciences, vol.102, issue.3, pp.892-897, 2005. ,
DOI : 10.1073/pnas.0408936102
Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response, Journal of Molecular Medicine, vol.72, issue.12, pp.1421-1428, 2007. ,
DOI : 10.1007/s00109-007-0251-9
Glutamine Repeats and Neurodegeneration, Annual Review of Neuroscience, vol.23, issue.1, pp.217-247, 2000. ,
DOI : 10.1146/annurev.neuro.23.1.217